Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger

Vaccine

Volumn 22, Issue 25-26, 2004, Pages 3303-3311

  Chippaux, J P ^a,e   Garba, A ^a   Ethevenaux, C ^b   Campagne, G ^a   De Chabalier, F ^a   Djibo, S ^a   Nicolas, P ^c   Ali, H ^a   Charrondiere M ^b   Ryall, R ^b   Bybel, M ^b   Schuchat, A ^d  

^a Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

^b SANOFI PASTEUR   (France)

^c SERVICE DE SANTÉ DES ARMÉES   (France)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

Author keywords

Immunogenicity; Neisseria meningitidis conjugate vaccine; Safety

Indexed keywords

DIPHTHERIA VACCINE; MENINGOCOCCUS VACCINE; POLIOMYELITIS VACCINE; POLYSACCHARIDE;

ANEMIA; ARTICLE; BLOOD GROUP TYPING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FEVER; HEPATITIS; HERNIA; HUMAN; IMMUNOGENICITY; INTOXICATION; LARYNGITIS; MAJOR CLINICAL STUDY; MALARIA; MALE; MALNUTRITION; MENINGITIS; NEISSERIA MENINGITIDIS; NIGER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SERUM BACTERICIDAL ACTIVITY; VACCINATION;

BLOOD BACTERICIDAL ACTIVITY; DIPHTHERIA TOXOID; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOLOGIC MEMORY; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NASOPHARYNX; NIGER; VACCINES, COMBINED; VACCINES, CONJUGATE;

EID: 4043093504     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.02.028     Document Type: Article

References (21)

1. Campagne G., Schuchat A., Djibo S., Ousseini A., Cissé L., Chippaux J.P. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-1996. Bull. World Health Org. 77:1999;499-508
2. Moore P.S., Plikaytis B.D., Bolan G.A., Oxtoby M.J., Yada A., Zoubga A., et al. Detection of meningitis epidemics in Africa: a population-based analysis. Int. J. Epidemiol. 21:1992;155-162
3. W.H.O. Detecting meningococceal meningitis epidemics in highly-endemic African countries: WHO recommendation. Week. Epidemiol. Rec. 2000;75:306-9.
4. Chippaux J.P., Debois H., Saliou P. A critical review of control strategies against meningococcal meningitis epidemics in Sub-Saharan African countries. Infection. 30:2002;216-224
5. Eskola J.H., Peltola H., Takala A.K., Kayhty H., Hakulinen M., Karanka V., et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N. Engl. J. Med. 317:1987;717-722
6. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19:2000;187-195
7. Borrow R., Goldblatt D.D., Andrews N., Southern J., Ashton L., Deane S., et al. Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom. J. Infect. Dis. 186:2002;1353-1357
8. Campagne G., Garba A., Fabre P., Schuchat A., Ryall R., Boulanger D., et al. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine followed by polysaccharide challenge in infants from Niger. Pediatr. Infect. Dis. J. 19:2000;144-150
9. Chippaux J.-P. Le CERMES de Niamey au Niger: Centre de Recherche sur les méningites et les schistosomoses. Méd Trop. 58:1998;199-203
10. Maslanka S.E., Gheesling L.L., Libutti D.E., Donaldson K.B., Harakeh H.S., Dykes J.K., et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays: the Multilaboratory Study Group. Clin. Diagn. Lab. Immunol. 4:1997;156-167
11. Carlone G.M., Frasch C.E., Siber G.R., Qnataert S., Gheesling L.L., Turner S.H., et al. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 30:1992;154-159
12. Gheesling L.L., Carlone G.M., Pais L.B., Holder P.F., Maslanka S.E., Plikaytis B.D., et al. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J. Clin. Microbiol. 32:1994;1475-1482
13. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus. Part II. Development of natural immunity. J. Exp. Med. 129:1969;1327-1348
14. Lepow M.L., Goldschneider I., Gold R., Randolph M., Gotschlich E.C. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics. 60:1977;673-680
15. Jodar L., Stephens D., Feavers I.M. Assay parameters and methods of data analysis for the comparison of complement sources in the Neisseria meningitidis serogroup C serum bactericidal assay. Biologicals. 30:2002;323-329
16. Chabalier F. de, Garba A., Chippaux J.P. Enquête de couverture vaccinale par sondage en grappes après une campagne de vaccination antiméningococcique de masse, Niamey (Niger). Cahiers Santé 11:2001;173-176
17. Riou J.Y., Djibo S., Sangaré L., Lombart J.P., Fagot P., Chippaux J.P., et al. A predictable comeback: the second pandemic of infections due to Neisseria meningitidis serogroup A subgroup III-1 in Africa in 1995. Bull. World Health Org. 74:1996;181-187
18. Nicolas P., Decousset L., Riglet V., Castelli P., Stor R., Blanchet G. Multilocus sequence typing of serogroup A meningococci isolated in Africa between 1988 and 1999 shows the clonal expansion of ST-5 and emergence of ST-7. Emerg. Infect. Dis. 7:2001;849-854
19. MacLennan J., Obaro S., Deeks J., Lake D., Elie C., Carlone G., et al. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy. J. Infect. Dis. 183:2001;97-104
20. Gold R., Lepow M.L., Goldschneider I., Gotschlich E.C. Immune response of human infants to polysaccharide vaccines of group A and C Neisseria meningitidis. J. Infect. Dis. 136:1977;S31-S35
21. Gotschlich E.C., Rey M., Triau R., Sparks K.J. Quantitative determination of the human immune response to immunization with meningococcal vaccines. J. Clin. Invest. 51:1972;89-96